- In June 2025, researchers at Northern Arizona University launched OpenExo, a groundbreaking open-source platform for robotic exoskeletons. Designed for rehabilitation and mobility applications, OpenExo offers global developers access to design files, control software, and documentation, democratizing access to exoskeleton research tools and accelerating innovation in the rehabilitation space. This initiative marks a significant step toward enhancing accessibility and customization of robotic rehabilitation technologies worldwide
- In January 2025, Ekso Bionics expanded its clinical footprint by partnering with Allegheny Health Network to deploy EksoNR in outpatient neurorehabilitation settings. This marked the first FDA-cleared robotic exoskeleton used outside inpatient rehab for stroke and brain injury patients. The expansion aims to make robotic gait therapy more accessible, improving recovery timelines and patient outcomes in community-based settings
- In June 2025, Wandercraft announced a successful Series D funding round totaling USD 75 million, aimed at accelerating global expansion and commercialization of its AI-powered robotic exoskeleton, Atalante X. In addition, Wandercraft secured FDA clearance for Atalante X—its second FDA nod—making it one of the few exoskeletons approved for rehabilitation in the U.S. healthcare system. These milestones underscore the company's leadership in full lower-limb exoskeleton technologies for stroke and neurological rehab
- In December 2024, engineers at KAIST (Korea Advanced Institute of Science and Technology) unveiled the WalkON Suit F1, a full-body robotic exoskeleton capable of assisting paraplegic users with walking, stair-climbing, and side-stepping. The exosuit, weighing 50kg and powered by 12 motors, received gold at the Cybathlon 2024 in the exoskeleton race. The suit represents a new frontier in assistive wearable technology tailored for independence and mobility in daily life
- In February 2025, ReWalk Robotics Ltd. announced clinical trials for its ReStore Exo-Suit, designed for stroke rehabilitation and mobility improvement in outpatient settings. Early findings show significant improvements in gait speed and balance among users. The company plans broader commercialization following regulatory reviews in North America and Europe, highlighting the increasing role of wearable robotics in physical therapy and patient mobility support
